IMA vs WDAY · rev $9.2M vs P/E 135, rev $8.45B
ImageneBio, Inc. (IMA) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported WDAY revenue for 2025-01-31 was $8.45B. Net income was $526.0M. Revenue was up 16.4% from 2024-01-31 to 2025-01-31. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
IMA currently screens at market cap $64.7M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the IMA and WDAY stock pages for the full models.
Not investment advice.